Treatment
Personalized neoantigen tumor vaccine clinical trials
We’re tracking 27 recruiting studies that include Personalized neoantigen tumor vaccine, each written for real people, not researchers, below.
Recruiting studies
- NCT07495215RecruitingPhase 1/Phase 2
Personalized mRNA vaccine plus immunotherapy for liver cancer after surgery
This trial tests a personalized mRNA vaccine (iNeo-Vac-R01) combined with a PD-1 inhibitor to prevent liver cancer from coming back after surgery. It is for people with early-stage liver cancer who have a high risk of recurrence.
Hangzhou, ZhejiangAges 18–75 - NCT05886439RecruitingPhase 1/Phase 2
Study drug plus PD-1 or PD-L1 for lung cancer
This Phase 1/2 trial tests a new treatment called LK101 combined with a PD-1 or PD-L1 antibody for advanced lung cancer. It may help shrink tumors and improve control of the disease, especially after prior anti–PD-1/PD-L1 treatment has stopped working.
Beijing, Beijing MunicipalityAges 18 years+ - NCT03606967RecruitingPhase 2
Individualized vaccine added to standard treatment for metastatic triple-negative breast cancer
This Phase 2 trial tests whether adding a personalized cancer vaccine to durvalumab (an immunotherapy), tremelimumab (another immunotherapy), and chemotherapy can improve outcomes for people with metastatic triple-negative breast cancer. It may help your immune system recognize your specific tumor features.
Orange, CaliforniaAges 18 years+
Common questions
- Are there clinical trials studying Personalized neoantigen tumor vaccine?
- Yes. Clin2 currently lists 27 recruiting studies that include Personalized neoantigen tumor vaccine, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Personalized neoantigen tumor vaccine trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Personalized neoantigen tumor vaccine an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Personalized neoantigen tumor vaccine or a specific trial is right for you.
Related treatments
- Neoantigen-based peptide vaccine
- Neoantigen-loaded DC vaccine
- Neoantigen Peptide Vaccine
- Tumor Infiltrating Lymphocytes
- Autologous Tumor Infiltrating Lymphocytes
- Influenza vaccine
- Recombinant Respiratory Syncytial Virus Vaccine
- Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
- Active Comparator vaccine
- BCG vaccine
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.